HEPATOCELLULAR CARCINOMA RESECTABLE
Clinical trials for HEPATOCELLULAR CARCINOMA RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA RESECTABLE trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in shrinking liver tumors before surgery
Disease control Recruiting nowThis study tests whether giving a combination of two immunotherapy drugs (iIparomlimab and tuvonralimab) plus a targeted therapy (lenvatinib) before surgery can help shrink liver cancer and lower the chance of it coming back. About 33 adults with resectable liver cancer at high r…
Matched conditions: HEPATOCELLULAR CARCINOMA RESECTABLE
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Blood test may spot liver cancer return months before scans
Knowledge-focused Recruiting nowThis study looks at whether a simple blood test can predict if liver cancer will return after surgery. Researchers will track tiny bits of tumor DNA in the blood over time. The goal is to see if this test can find signs of cancer earlier than standard imaging. About 255 adults wi…
Matched conditions: HEPATOCELLULAR CARCINOMA RESECTABLE
Sponsor: Zhujiang Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:52 UTC